NEWS
-
Hongmin Chen joins WARF Therapeutics
Chen to head biology for program aiming to produce preclinical candidates CONTACT: Jeanan Yasiri Moe Director of Strategic Communications [email protected] | (608) 960-9892 MADISON, Wis. – WARF Therapeutics, the multimillion-dollar…
-
Industry leaders join WARF Therapeutics Advisory Board
CONTACT: Jeanan Yasiri Moe, Director of Strategic Communications [email protected] | 608.960.9892 Leaders from Celgene, Third Rock Ventures and other top pharma companies will help guide new drug discovery initiative at…
-
Despite the financial risks, new drug discovery vehicles proliferate on campus
Universities bet big on promising therapeutics 6.19.19 | Technology Transfer Tactics | Original Publication | Download the pdf There is nothing like a big hit in the pharmaceutical space to…
-
WARF bets big on new squad of drug hunters
2.27.19 | UW-Madison News | David Tenenbaum | Original Publication As it nears its 100th birthday, WARF — the Wisconsin Alumni Research Foundation, the nation’s first university technology transfer office…
EVENTS
-
Wed 28February 28 @ 11:00 am - 12:00 pmThe Role of Nuclear Receptors and Pioneer Factors in Cancer
The Role of Nuclear Receptors and Pioneer Factors in Cancer
Jason Carroll is a professor of molecular oncology at the University of Cambridge, a senior group leader at Cancer Research UK and a fellow at Clare College. His lab is…
For business questions, contact John Nagel or Rafael Diaz. If you are a PI interested in submitting your work to the program or talking through next steps, contact Jon Young. You do not need to have a patent; we are interested in talking with you about a new target early in your process.